VITRAKVI
20MG/ML POR SOL 2X50ML
| SÚKL code | 0250451 |
|---|---|
| Name of the product | VITRAKVI |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | VITRAKVI |
| Supplement | 20MG/ML POR SOL 2X50ML |
| Strenght | 20MG/ML |
| Pharmaceutical form | Oral solution |
| Package | 2X50ML |
| Route | Oral use |
| Wrap type | Bottle |
| Legal status | na lékařský předpis |
| Active substance |
LAROTRECTINIB SULFATE (LAROTRECTINIBI SULFAS) LAROTRECTINIB (LAROTRECTINIBUM) |
| ATC group | L01EX12 |
| ATC group name | LAROTREKTINIB |
Marketing authorisation information
| Registration Number | EU/1/19/1385/004 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Bayer AG, Leverkusen |
| MA Holder country | NĚMECKO |
cz